Clinical Trials Browser

Pruritus × Clear all

Abscess, Chronic Urticaria, Angioedema, Dermatitis, Atopic, Eczema, Erythema, Exanthema, Mycosis Fungoides, Neoplasms, Photosensitivity Disorders, Pruritus, Psoriasis, Urticaria, Hidradenitis Suppurativa, Plaque, Amyloid

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

30 enrolled

Pruritus

NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Phase NA Completed

40 enrolled

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT06688643 2024-11-14

The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit

Phase NA Completed

58 enrolled

Genitourinary

Urinary Bladder Neoplasms, Pruritus, Postoperative Nausea and Vomiting

NCT04018209 2024-11-01

PANAM

Completed

170 enrolled

Myeloid

Myeloproliferative Disorders, Pruritus

NCT03721172 2024-05-29

ADVANCE

Phase 3 Completed

595 enrolled 19 charts

Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis

NCT04333108 2023-05-06

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Phase 3 Unknown

140 enrolled

Myeloid

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

NCT02811783 2022-10-28

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Phase 3 Terminated

59 enrolled

DermatologicLymphoid

Mycosis Fungoides, Pruritus, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT03673878 2022-01-27

PRURI-C

Completed

200 enrolled

CNS

Brain Neoplasms, Pruritus

NCT02646020 2021-05-18

EGFR-TKIs

Phase 2 Completed

138 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT03796052 2020-11-04

Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients

Phase NA Completed

53 enrolled

Ichthyosis, Pruritus

NCT00814073 2019-12-03

AB06006

Phase 3 Completed

135 enrolled

Myeloid

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

NCT01815424 2019-04-16

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Phase 3 Completed

266 enrolled 58 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01186744 2018-12-26

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

666 enrolled 110 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

1,101 enrolled 46 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

NCT03340155 2017-11-13

BioUV2017

Phase NA Unknown

240 enrolled

DermatologicLymphoidMyeloid

Eczema, Graft vs Host Disease, Lichen Planus, Lymphoproliferative Disorders, Mastocytosis, Prurigo, Pruritus, Psoriasis, Vitiligo, Lymphoma, T-Cell, Cutaneous

NCT03290989 2017-09-25

PRURITCC

Completed

100 enrolled

Dermatologic

Pruritus, Skin Neoplasms

NCT01625455 2017-05-10

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Phase 4 Terminated

7 enrolled 7 charts

Lymphoid

Pruritus, Sezary Syndrome

NCT01831466 2015-11-25

Tofacitinib Ointment For Chronic Plaque Psoriasis

Phase 2 Completed

476 enrolled 33 charts

Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis, Skin Diseases

NCT01801670 2015-01-27

Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

Withdrawn

DermatologicLymphoid

Mycosis Fungoides, Pruritus, Lymphoma, T-Cell, Cutaneous

NCT01276639 2014-09-19

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

901 enrolled 56 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT00863395 2014-03-31

CTCL

Phase 1/2 Terminated

6 enrolled

DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous

Clinical Trials

SKINERGY

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit

PANAM

ADVANCE

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

PRURI-C

EGFR-TKIs

Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients

AB06006

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

BioUV2017

PRURITCC

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Tofacitinib Ointment For Chronic Plaque Psoriasis

Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

CTCL